(IN BRIEF) Novo Nordisk has announced separate research collaborations with Omega Therapeutics and Cellarity Inc. to explore innovative treatment approaches for obesity and MASH (Metabolic Associated Fatty Liver Disease). The collaboration with Omega aims to develop an epigenomic controller to … Read the full press release →
Posted in Business, Denmark, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Cellarity Inc., Fabrice Chouraqui, innovative, Mahesh Karande, Marcus Schindler, MASH (Metabolic Associated Fatty Liver Disease), Novo Nordisk, Obesity, Omega Therapeutics, partnership, Paul Biondi, sustainability, treatments, USA